Please find attached Revised Financials for the year ended 31.03.2025.
Awaiting price reaction for this filing.
Blueblood Ventures Ltd submitted revised audited financial results for FY25, with the statutory auditor (KRA & Associates) issuing an unmodified opinion. Revenue from operations stayed nearly flat at Rs 50.02 lakhs (vs Rs 51.15 lakhs in FY24), while profit after tax fell sharply to Rs 0.59 lakhs from Rs 2.44 lakhs. The auditor flagged three Emphasis of Matter items: Rs 5,656.71 lakhs in unconfirmed advance balances treated as recoverable, 247 Zero Optional Convertible Debentures (out of 4,149) worth about Rs 24.7 lakhs that were wrongly transferred to an unrelated party, and Rs 1.61 lakhs in unpaid TDS. Operating cash flow was deeply negative at Rs (320.73) lakhs, and long-term borrowings remain heavy at Rs 9,400 lakhs against a small equity base of Rs 300.11 lakhs.
The revision combined with auditor concerns around unconfirmed receivables, wrongly transferred debentures, and weak cash generation suggests governance and asset-quality worries for shareholders, even though the headline opinion remains clean. The stock is likely to see limited investor interest given negligible profitability and high leverage.